Department of Surgery, Division of Surgical Oncology, Duke University School of Medicine, Durham, NC, USA.
Division of Pediatric Infectious Diseases, Associate Director of the Duke Microbiome Center, Duke University, Durham, NC, USA.
Nature. 2023 Aug;620(7972):E1-E6. doi: 10.1038/s41586-023-06292-1. Epub 2023 Aug 2.
A growing body of literature suggests that alterations in the human microbiome are causative of disease initiation and progression. Aykut et al. present data supporting the argument that alterations in the gut fungal microbiome (the “mycobiome”), along with the presence of fungal elements within pancreatic tissue (specifically those of the genus , are associated with pancreatic oncogenesis. Upon analyzing the human sequencing data presented in the original manuscript, we found few fungal reads in pancreatic tissue samples and did not identify differences in pancreatic or gut mycobiome composition between healthy and pancreatic ductal adenocarcinoma (PDAC) patients. Our re-analysis of these data does not support an association between an intrinsic pancreatic mycobiome and the development of human PDAC, and illustrates the challenges in analyzing microbiome sequencing data from low biomass samples.
越来越多的文献表明,人类微生物组的改变是疾病发生和发展的原因。Aykut 等人提供的数据支持了这样一种观点,即肠道真菌微生物组(“真菌组”)的改变,以及胰腺组织内真菌成分的存在(特别是属的那些成分)与胰腺癌变有关。在分析原始手稿中呈现的人类测序数据时,我们在胰腺组织样本中发现了很少的真菌读数,并且在健康个体和胰腺导管腺癌 (PDAC) 患者之间没有发现胰腺或肠道真菌组组成的差异。我们对这些数据的重新分析不支持内在胰腺真菌组与人类 PDAC 发展之间的关联,并说明了从低生物质样本分析微生物组测序数据的挑战。